Immunoblotting using PHF1 (anti-phospho-S396 and phospho-S404 tau) showed that hyperphosphorylated tau was present in EV fractions 3–8 from the brains of individuals with AD (Extended Data Fig. 5a). This evidence concerns the gene MAPT and Alzheimer disease.